RELATED PARTY TRANSACTIONS	9 Months Ended
Jun. 30, 2018
RELATED PARTY TRANSACTIONS [Abstract]
RELATED PARTY TRANSACTIONS	8. RELATED PARTY TRANSACTIONS During the normal course of its business, the Company enters into various transactions with entities that are both businesses and individuals. The following is a summary of the related party transactions during the three and nine months ended June 30, 2018 and 2017. Eurema Consulting Eurema Consulting S.r.l. was a significant shareholder of Arna Therapeutics Limited. During the three and nine months ended June 30, 2018 and 2017, Eurema Consulting S.r.l. did not supply the Company with consulting services. As of June 30, 2018, and September 30, 2017, Eurema Consulting S.r.l was owed $200,000 and $200,000, respectively, by the Company for past consultancy services. Gabriele Cerrone Gabriele Cerrone was a Director of Arna Therpeutics Limited. During the three and nine months ended June 30, 2018 and 2017, Gabriele Cerrone did not supply the Company with consulting services. As of June 30, 2018, and September 30, 2017, the balance due to Gabriele Cerrone was $175,000 and $175,000, respectively for past consultancy services. Roberto Pellicciari Roberto Pellicciari was a Director of Arna Therpeutics Limited and sole shareholder of TES Pharma Srl. During the three and nine months ended June 30, 2018 and 2017, Roberto Pellicciari did not supply the Company with consulting services. As of June 30, 2018, and September 30, 2017, the balance due to Roberto Pellicciari was $175,000 and $175,000, respectively for past consultancy services. Other related party transactions are discussed in Note 9, Commitments and contingencies. There is no interest charged on the balances with related parties. There are no defined repayment terms and such amounts can be called for payment at any time.

RELATED PARTY TRANSACTIONS

9 Months Ended

Jun. 30, 2018

8. RELATED PARTY TRANSACTIONS

During the normal course of its business, the Company enters into various transactions with entities that are both businesses and individuals. The following is a summary of the related party transactions during the three and nine months ended June 30, 2018 and 2017.

Eurema Consulting

Eurema Consulting S.r.l. was a significant shareholder of Arna Therapeutics Limited. During the three and nine months ended June 30, 2018 and 2017, Eurema Consulting S.r.l. did not supply the Company with consulting services. As of June 30, 2018, and September 30, 2017, Eurema Consulting S.r.l was owed $200,000 and $200,000, respectively, by the Company for past consultancy services.

Gabriele Cerrone

Gabriele Cerrone was a Director of Arna Therpeutics Limited. During the three and nine months ended June 30, 2018 and 2017, Gabriele Cerrone did not supply the Company with consulting services. As of June 30, 2018, and September 30, 2017, the balance due to Gabriele Cerrone was $175,000 and $175,000, respectively for past consultancy services.

Roberto Pellicciari

Roberto Pellicciari was a Director of Arna Therpeutics Limited and sole shareholder of TES Pharma Srl. During the three and nine months ended June 30, 2018 and 2017, Roberto Pellicciari did not supply the Company with consulting services. As of June 30, 2018, and September 30, 2017, the balance due to Roberto Pellicciari was $175,000 and $175,000, respectively for past consultancy services.

Other related party transactions are discussed in Note 9, Commitments and contingencies.

There is no interest charged on the balances with related parties. There are no defined repayment terms and such amounts can be called for payment at any time.